FDA announced it is taking steps to curb illicit importation of the animal sedative xylazine, which is frequently being mixed with illegal street drugs.

FDA issued an EUA on February 24, 2023, for the first at-home OTC diagnostic test that can differentiate and detect influenza A and B and the SARS-CoV-2 virus.

While most parents and caregivers recognize that a low-grade fever helps a child’s body fight off infection, a new poll from University of Michigan researchers finds that one in three parents would give fever-reducing medication for spiked temperatures below 100.4°F, which isn’t recommended.